![Anne Chun Longo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Chun Longo
Vorstandsvorsitzender bei PharmatrophiX, Inc.
Profil
Anne Chun Longo is currently the Chief Executive Officer at PharmatrophiX, Inc. She started this position in 2006.
She completed her undergraduate degree at Stanford University.
Aktive Positionen von Anne Chun Longo
Unternehmen | Position | Beginn |
---|---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Vorstandsvorsitzender | 01.01.2006 |
Ausbildung von Anne Chun Longo
Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |